International Transplant Skin Cancer Collaborative

International Transplant Skin Cancer Collaborative Mission Statement
	To integrate and support basic scientific and clinical research to address the special needs of transplant recipients with skin cancer in order to improve quality of care.
	To educate patients, scientists, primary care doctors and specialist physicians on the unique needs and clinical care issues in the transplant patients.
	Fact: Skin cancer is the most common cancer affecting solid organ transplant recipients, affecting up to 70 percent of patients within 20 years, and is the result of intense immunosuppressive regimens.

Learn more through the AT-RISC* Alliance
*AT-RISC: After Transplantation - Reduce Incidence of Skin Cancer
http://www.at-risc.org

A limited amount of patient information brochures are available. Visit the AT-RISC Web site to preview the brochure and email your name, type of involvement with transplant patients, address and FedEx or UPS number to info@itscc.org to order.

MEMBERSHIP & BUSINESS MEETING March 5, San Francisco, CA

Join your colleagues at the San Francisco Marriott (room Golden Gate A2 & A3) 5 - 8 pm Contact Kim Schardin (kschardin@itscc.org) for more details.

INTERNATIONAL SYMPOSIUM on SKIN DISEASES IN ORGAN TRANSPLANT RECIPTENTS May 7 - 10, 2009, Thessaloniki, Greece

Dear SCOPE members and other colleagues,

The "SCOPE meetings" have become major meetings for clinicians and basic scientists working in the challenging fields of cutaneous problems (e.g. skin cancer and skin infections) in organ transplant recipients.

After fruitful meetings in Berlin, Lyon, London, Stockholm, Barcelona, Dublin and Venice, we are now meeting in Thessaloniki, Greece.

The Congress will cover all aspects of skin problems in organ transplant recipients and ways of intervention and treatment. Invited lectures will be given by experienced researchers in this specific field. The participants are invited to submit an abstract of which the most interesting will be selected for oral presentation.

Except for oral presentations there will also be ample time for informal contacts between clinicians and scientist who are involved in skin care in organ transplant recipients to exchange ideas and treatment options in this field. This exchange of knowledge is the key factor for innovative development in SCOPE.

We will make every effort to ensure the success of the meeting, hoping many clinicians and researchers will participate in the scientific and social program of this meeting.

It is my pleasure to invite you to this unique Meeting of SCOPE in Thessaloniki, Greece.

Jan Nico Bouwes Bavinck
President of SCOPE

Learn more and register: http://www.scopenetwork.org/34.htm

Learn more about our sister organization in Europe. You may also access the site by clicking on the SCOP Network graphical link on the left column of this page.